NaturalShrimp CEO Issues Shareholder Update
NaturalShrimp, Inc. (OTCQB: SHMP) announced significant developments in a recent letter to shareholders. The company is transitioning to commercialization of its patented Recirculating Aquaculture System (RAS) technology. Key updates include finalizing a Distribution Agreement in Florida with projected sales of $300,000 to $500,000 for Q4 2021, extensive shrimp stocking in Webster City, and advancements towards full capacity in LaCoste. The company aims for a NASDAQ uplist by mid-November 2021, with potential for institutional investments. NaturalShrimp estimates being cash flow positive by Q2 2022.
- Finalizing Distribution Agreement in Florida, projecting Q4 sales between $300,000 to $500,000.
- Weekly shrimp stocking initiated in Webster City, targeting 9,000 pounds production by Q2 2022.
- Anticipating NASDAQ uplist by mid-November 2021 to attract institutional investments.
- Expecting cash flow positivity from sales and licensing agreements between Q1 and Q2 2022.
- Delays in full production capacity at LaCoste due to Covid supply chain issues.
- Approximately $5M debt secured by Webster City facilities.
DALLAS, TX, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), has issued a letter to shareholders from its Chief Executive Officer, Gerald Easterling.
Dear Shareholders:
2021 has been a pivotal year for NaturalShrimp from a commercial and operational perspective and I am now happy to report that the foundation building is complete, and the commercialization phase of our disruptive RAS (Recirculating Aquaculture System) technology has begun. Let’s review some key milestones on the horizon that will strategically position NaturalShrimp to deliver material revenues and positive cash flow operations in 2022 and beyond.
Sales and Sale Distribution Agreements: The Company is finalizing a Distribution Agreement with a distributor in the Tampa/St. Petersburg, Florida region. We are expecting sales at
Webster City, IA Update: The Company has begun weekly stocking and growout of shrimp in one of the Webster City barns in preparation for achieving weekly harvests. After successful integration and testing of our patented filtration equipment in the first barn, the Company has begun retrofit of the other remaining four barns. The retrofit will be complete with projected production capacity of 9,000 pounds per week by the second calendar quarter of 2022.
LaCoste, TX Update: The Company continues to work towards full capacity at the plant in LaCoste. We expect that sales for this quarter will come from the LaCoste facility also. We, as other companies, have experienced delays caused by Covid supply chain issues but we expect ramping up full production of 3,000 pounds per week by the end of the first quarter 2022. Also, the Company is expecting to break ground on an 80,000 square foot expansion in LaCoste within the next sixty days.
Florida Opportunity: Our CFO, William Delgado, met with state and local government officials in late September regarding an approximately
Licensing: The Company is in active negotiations with a Salmon producer on a license of the NSI technology, specifically around the technology from our most recent acquisition, Hydrensis. We have been approached by several groups regarding licensing of our technology. We will entertain license opportunities in all areas of aquaculture except for the production of shrimp.
NASDAQ Uplist: The Company expects to complete its last administrative item concerning the uplist sometime around November 15, 2021. Depending on the NASDAQ schedule, we are hoping to be uplisted within the next 90 days. This uplist is very important in that the Company will have the ability to attract institutional ownership and research coverage.
Financial Update: The Company currently has approximately
In conjunction with our Nasdaq uplisting, the Company will commence a regular cadence of financial reporting starting for the quarter ended September 30, 2021 to be reported in mid-November and will commence regular financial results conference calls starting for the quarter ended December 31, 2021. Management also expects to host a business update conference call in the fourth quarter of 2021 to introduce calendar year 2022 financial and operational milestones. The Company is also scheduled to attend the Roth 10th Annual Technology & Inaugural AgTech Answers Virtual Event, which is taking place November 16-18, 2021.
About NaturalShrimp
NaturalShrimp, Inc. is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas and Webster City, Iowa. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. For more information visit www.naturalshrimp.com.
Forward-Looking Statements
This press release contains a number of forward-looking statements that reflect management’s current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements.
Investor Relations Contact
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
SHMP@mzgroup.us
FAQ
What are NaturalShrimp's projected sales for Q4 2021?
When does NaturalShrimp expect to be cash flow positive?
What is the status of NaturalShrimp's NASDAQ uplist?
How much shrimp does NaturalShrimp plan to produce weekly by Q2 2022?